Editorial Comment zu: Stepp H. et al.: Fluoreszenzdiagnostik und Photodynamische Therapie in der Urologie

Literatur

• 1 Grimbergen M C, Swol C F van, Jonges T G, Boon T A, Moorselaar R J van. Reduced specificity of ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy.  Eur.Urol.. 2003;  44 51-56
• 2 Jain S, Kockelbergh R C. The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer.  BJU.Int.. 2005;  96 17-21
• 3 Vogeli T A. The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives.  BJU.Int.. 2005;  96 1171-1176
• 4 Devere White RW. Transurethral resection of superficial bladder cancer using 5-aminolevulinic acid: are there any long-term benefits?.  Nat.Clin.Pract.Urol.. 2006;  3 254-255
• 5 Chatterton K, Ray E, O’Brien T S. Fluorescence diagnosis of bladder cancer.  Br. J.Nurs.. 2006;  15 595-597
• 6 Frampton J E, Plosker G L. Hexyl aminolevulinate in the detection of bladder cancer: profile report.  BioDrugs.. 2006;  20 317-320
• 7 Jichlinski P. Photodynamic applications in superficial bladder cancer: facts and hopes!.  J.Environ.Pathol.Toxicol.Oncol.. 2006;  25 441-451
• 8 Frampton J E, Plosker G L. Hexyl aminolevulinate: in the detection of bladder cancer.  Drugs.. 2006;  66 571-578